Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Omega Ag Seeds (Punjab) Ltd

OMEAG
BSE
10.98
4.97%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Omega Ag Seeds (Punjab) Ltd

OMEAG
BSE
10.98
4.97%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
9Cr
Close
Close Price
10.98
Industry
Industry
Trading
PE
Price To Earnings
14.08
PS
Price To Sales
5.26
Revenue
Revenue
2Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
-325.93%
Peer Comparison
How does OMEAG stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
OMEAG
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000000002
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000002
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
4.8
Other Income
Other IncomeCr
000000001000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000001000
Tax
TaxCr
000000000000
PAT
PATCr
000000001000
Growth YoY
PAT Growth YoY%
-325.0-25.020.020.076.5100.0-300.0-75.01,550.087.5214.3
NPM
NPM%
4.8
EPS
EPS
-0.2-0.1-0.1-0.1-0.10.0-0.2-0.10.70.00.00.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
401000000002
Growth
Revenue Growth%
513.7-88.44.0-100.0
Expenses
ExpensesCr
411000900002
Operating Profit
Operating ProfitCr
000000-900000
OPM
OPM%
-2.9-26.3-23.73.0
Other Income
Other IncomeCr
000000100011
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000-800001
Tax
TaxCr
000000000000
PAT
PATCr
000000-800001
Growth
PAT Growth%
82.3-45.214.0-98.02,178.418.0-51,766.099.1-272.837.3298.176.3
NPM
NPM%
1.15.35.837.0
EPS
EPS
0.10.00.00.00.00.0-10.3-0.1-0.3-0.20.40.8

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Dec 2025
Equity Capital
Equity CapitalCr
888888888888
Reserves
ReservesCr
000000-8-8-8-9-8-8
Current Liabilities
Current LiabilitiesCr
111211700111
Non Current Liabilities
Non Current LiabilitiesCr
000000000000
Total Liabilities
Total LiabilitiesCr
9991099700001
Current Assets
Current AssetsCr
222210000001
Non Current Assets
Non Current AssetsCr
788888700000
Total Assets
Total AssetsCr
9991099700001

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
000000-1-7000
Investing Cash Flow
Investing Cash FlowCr
00000017000
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
000000-1-7000
CFO To PAT
CFO To PAT%
-127.8-122.3-159.3-5,032.2-81.2-26.515.09,913.10.00.0-28.2
CFO To EBITDA
CFO To EBITDA%
49.424.939.320.57.12.313.94,932.00.00.042.0

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
136844000006
Price To Earnings
Price To Earnings
281.7273.0247.50.0226.00.00.00.00.00.018.2
Price To Sales
Price To Sales
3.113.215.3
Price To Book
Price To Book
1.70.81.00.50.40.00.00.00.00.0-23.6
EV To EBITDA
EV To EBITDA
-106.8-49.5-64.1-27.4-23.20.00.00.10.00.1-29.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
1.64.54.4
OPM
OPM%
-2.9-26.3-23.7
NPM
NPM%
1.15.35.8
ROCE
ROCE%
0.90.70.50.00.20.39,665.647.063.628.5245.6
ROE
ROE%
0.60.30.40.00.20.29,666.047.063.628.5-129.8
ROA
ROA%
0.50.30.30.00.20.2-110.7-265.2-1,296.3-348.790.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Omega Ag-Seeds (Punjab) Limited is an Indian listed entity currently executing a fundamental strategic pivot. Historically a specialized player in the agricultural seed trade, the company is aggressively diversifying its corporate mandate to include high-growth sectors such as **Ayurvedic pharmaceuticals**, **specialty oils**, and **healthcare services**. While the company has faced periods of operational dormancy and a suspension of trading on the **BSE**, recent financial recoveries and structural reforms indicate a concerted effort to revitalize shareholder value through a broader life-sciences and agro-processing platform. --- ### **Strategic Pivot: From Agri-Trading to Life Sciences** The company has formally amended its **Main Objects** in the **Memorandum of Association (MOA)** to transition from a single-segment trading firm into a diversified conglomerate. This expansion is designed to provide the agility required to capitalize on emerging market trends in India’s wellness and healthcare sectors. * **Ayurvedic & Pharmaceutical Division:** The company is authorized to manufacture, formulate, and trade in **Ayurvedic medicines**, dietary supplements, biologicals, and vaccines. This includes **contract manufacturing** and R&D initiatives both domestically and internationally. * **Healthcare & Distribution:** New mandates allow the company to operate as **chemists and druggists**, focusing on the distribution of medicinal preparations, including the **vialling, bottling, and repacking** of tablets, capsules, and syrups. * **Specialty Oils & Processing:** The company is moving into the processing and refining of **crude, refined, and perfumed oils** derived from various oil-bearing commodities. * **Core Agricultural Business:** Maintenance of its traditional roots in the **purchasing, selling, and exporting** of edible and non-edible seeds, pulses, grains, and nursery products. --- ### **Financial Performance & Earnings Recovery** After a period of inconsistent performance, the company’s recent filings under **Ind AS** standards show a return to marginal profitability. The financial results for the period ending **December 31, 2025**, indicate a positive trend in **Earnings Per Share (EPS)**. **Comparative EPS Performance (Basic & Diluted):** | Reporting Period | EPS (₹) | Status | | :--- | :--- | :--- | | **Quarter Ended Dec 31, 2025** | **0.10** | Profit | | **Quarter Ended Sep 30, 2025** | **(0.03)** | Loss | | **Quarter Ended Dec 31, 2024** | **(0.09)** | Loss | | **Nine Months Ended Dec 31, 2025** | **0.04** | Profit | | **Nine Months Ended Dec 31, 2024** | **(0.30)** | Loss | | **Full Year Ended March 31, 2025** | **0.44** | Profit | **Key Financial Notes:** * **Audit Status:** Financial statements have received **unmodified conclusions** from statutory auditors, confirming compliance with **Section 133 of the Companies Act, 2013**. * **Investment Valuation:** In a conservative accounting move, equity investments are currently **valued at cost** rather than Fair Value, as fair value was deemed **not determinable** under Ind AS 109. * **Reserves:** No funds were transferred to **General Reserves** for the fiscal year ended **March 31, 2024**, due to the lack of active business operations during that specific cycle. --- ### **Capital Structure & Corporate Governance** The company is optimizing its capital base and governance framework to support its new business directions. While a massive increase in capital was recently considered, the board has opted for a more measured approach. * **Authorized Share Capital:** Currently stands at **Rs. 25,00,00,000** (divided into **2,50,00,000** shares of **Rs. 10** each). A proposal to increase this to **Rs. 60,00,00,000** was **rescinded** in January 2026 to maintain capital discipline. * **Paid-up Capital:** **Rs. 7,90,40,000** (comprising **79,04,000** Equity Shares). * **Governance Modernization:** The company adopted a **new set of Articles of Association (AOA)** in 2026 to align with modern regulatory frameworks. * **Key Appointments:** * **Mrs. Rekha Rani Naraniwal** appointed as Non-Executive Independent Director (Term: **2026–2031**). * **Kashinath Sahu & Co.** appointed as Secretarial Auditors (Term: **2025-26 to 2029-30**). * **Inorganic Growth:** A proposed merger with **M/s Somani Herbs and Agro Products India Private Limited** was recently **deferred** by Independent Directors for further evaluation. --- ### **Operational Infrastructure & Resource Status** Recent reporting cycles (FY 2022-23 and FY 2021-22) reflect a company in a "dormant-to-active" transition phase, with minimal physical manufacturing activity currently recorded. | Operational Metric | Status / Value | | :--- | :--- | | **Active Operating Segments** | **Single Segment** (Trading) | | **Power & Fuel Consumption** | **NIL** | | **Electricity Purchased** | **NIL** | | **Production Output** | **NIL** (Pending activation of new units) | | **Dividend Payout** | **NIL** (Retained for business reactivation) | --- ### **Risk Matrix & Market Challenges** Investors should note that Omega Ag-Seeds operates in a high-risk environment characterized by regulatory hurdles and environmental dependencies. * **Listing Status & Liquidity:** The equity shares are currently under **Suspension of Trading** on the **BSE**. Although the company has paid all **Annual Listing Fees** up to **2024-25**, it is currently awaiting **BSE approval** for the revocation of this suspension. * **Environmental Vulnerability:** The core agricultural business remains heavily dependent on the **monsoon**. Risks include **global warming**, **unseasonal rains**, and the reduced risk-taking capacity of rain-fed farmers. * **Structural Headwinds:** * **Land Availability:** Cultivable land is shrinking due to **real estate** and **industrial expansion**. * **Market Volatility:** Fluctuating agricultural prices impact sowing patterns and profit margins. * **Post-Harvest Inefficiency:** Significant value is lost due to inadequate harvesting and storage infrastructure. * **Strategic Mitigation:** The company is focusing on **Micro-irrigation** trends and aligning with government reforms aimed at **doubling farmer income** to mitigate these systemic risks.